Skip to main content

Table 2 Ten years overall survival of breast cancer patients using the 7 pDMGs associated with clinical outcome

From: DNA methylation profiles capturing breast cancer heterogeneity

Gene

Data Type

Hazard Ratio

P value

ABLIM1

Methylation

0.40

6.91E-03

Gene expression

2.03

1.23E-02

CPT1A

Methylation

0.35

3.64E-03

Gene expression

2.45

8.72E-04

FAM150B

Methylation

1.85

4.84E-02

Gene expression

0.49

1.53E-02

IFI35

Methylation

2.29

4.22E-02

Gene expression

0.57

3.53E-02

LBXCOR1

Methylation

2.65

8.55E-03

Gene expression

0.53

2.18E-02

MATK

Methylation

2.12

2.82E-02

Gene expression

0.44

4.77E-03

WNT10A

Methylation

2.96

1.11E-02

Gene expression

0.55

3.23E-02

  1. Cox regression analysis was used. Both methylation status and gene expression level were used for patient stratification